Copyright
©The Author(s) 2016.
World J Gastrointest Pathophysiol. Nov 15, 2016; 7(4): 314-319
Published online Nov 15, 2016. doi: 10.4291/wjgp.v7.i4.314
Published online Nov 15, 2016. doi: 10.4291/wjgp.v7.i4.314
Ref. | Country | Study design | Year | Total number | Study sample | Exposure definition | Exposure measurement | Outcome definition | Outcome ascertainment | Adjusted OR | Confounder adjustment | Quality assessment (Newcastle-Ottawa scale) |
Amin et al[16] | Australia | Cohort study | 2006 | 75834 in HCV patients | People notified with HCV infection to the New South Wales Health Department’s Notifiable Diseases Database between 1 January 1990 and 31 December 2002 (HCV group) and NSW population (control group) | HCV infection | Detection of anti-HCV antibody or HCV RNA | Renal cancer or kidney cancer | The NSW Central Cancer Registry with ICD-10 code C64 for kidney cancer and C65 for renal cancer | Kidney cancer 0.9 (0.6–1.4) | Age, sex and calendar year | Selection: 4 Comparability: 1 Outcome: 3 |
Malagu arnera et al[21] | Italy | Case control study | 2006 | 315 (15 case and 300 control) | Elderly kidney cancer patients attending geriatric department (case) and elderly volunteers (control) | Positive Anti-HCV | Detection of Anti-HCV antibody using enzyme-linked immunosorbent assay. Assay positive samples were confirmed by immunoblotting | Kidney cancer | N/A | 10.29 (3.49-30.36) | None | Selection: 3 Comparability: 0 Outcome: 2 |
Omland et al[22] | Denmark | Cohort study | 2010 | 4204 in HCV patients | Acute or chronic HCV infected patients listed in the Danish National Hospital Registry between 1994 and 2003 without previous diagnosis of cancer (HCV) and general population (control) | Acute or chronic HCV infection | ICD-10 code (B17.1 and B18.2) from the Danish National Hospital Registry | Kidney cancer | The Danish Cancer Registry with ICD-7 code 180 | 3.60 (0.98–9.22) | Age, sex and year of diagnosis | Selection: 4 Comparability: 1 Outcome: 2 |
Gordon et al[19] | United States | Cohort study | 2010 | 67063 | HCV-tested patients (both positive and negative) between 1997 and 2006 from administrative data from Henry Ford hospital | HCV infection | Positive anti-HCV test using enzyme-linked immunosorbent assay, confirmed by a documented positive molecular assay for HCV RNA | Renal cell carcinoma | Health system cancer registry, confirmed by medical record and pathology report review | 1.77 (1.05-2.98) | Age, race, gender, chronic kidney disease | Selection: 4 Comparability: 1 Outcome: 3 |
Budakoğlu et al[17] | Turkey | Case-control study | 2011 | 6170 (903 case and 5267 control) | Patients who had histologically proven renal cell carcinoma diagnosis between 2005 to 2010 from six tertiary cancer centers (case) and healthy people who were living in the same geographic regions (control) | Positive anti-HCV | Positive anti-HCV test using enzyme-linked immunosorbent assay | Renal cell carcinoma | Histopathology report | 1.08 (0.62-1.88) | None | Selection: 3 Comparability: 0 Outcome: 3 |
Hofmann et al[20] | Sweden | Cohort study | 2011 | 43000 in HCV patients | All Swedish residents diagnosed with HCV infection between 1990 and 2006 (HCV group) and general population (control) | Chronic HCV infection | The national surveillance database at the Swedish Institute for Infectious Disease Control | Kidney cancer | The national Cancer register with ICD-7 code 180.0 and 180.9 and histologic confirmation | 1.2 (0.8–1.7) | Age, sex and calendar year | Selection: 4 Comparability: 1 Outcome: 3 |
Gonzalez et al[18] | United States | Case-control study | 2015 | 240 (140 case and 100 control) | Newly diagnosed renal cell carcinoma (case) and newly diagnosed colon cancer patients (control) | Chronic HCV infection | Detection of anti-HCV antibody or HCV RNA | Renal cell carcinoma | Histopathology report | Positive HCV RNA 24.20 (2.4 - > 999.9) | Sex, age, race, BMI, smoking, alcohol abuse, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, congestive heart failure, chronic kidney disease, cirrhosis | Selection: 3 Comparability: 2 Outcome: 3 |
- Citation: Wijarnpreecha K, Nissaisorakarn P, Sornprom S, Thongprayoon C, Thamcharoen N, Maneenil K, Podboy AJ, Cheungpasitporn W. Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis. World J Gastrointest Pathophysiol 2016; 7(4): 314-319
- URL: https://www.wjgnet.com/2150-5330/full/v7/i4/314.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v7.i4.314